Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab

Clinical and Experimental Dermatology

Volumn 33, Issue 1, 2008, Pages 43-45

  Fallon, J C ^a   Patchett, S ^a   Gulmann, C ^a   Murphy, G M ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIUM; CLARITHROMYCIN; DOXYCYCLINE; FORMALDEHYDE; INFLIXIMAB; IRON; MESALAZINE; MINOCYCLINE;

ADD ON THERAPY; ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CASE REPORT; CROHN DISEASE; DRUG INFUSION; DRUG SUBSTITUTION; FEMALE; HUMAN; HUMAN TISSUE; LEG; LONG TERM CARE; MYCOBACTERIOSIS; MYCOBACTERIUM MARINUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SWIMMING; TISSUE FIXATION; TREATMENT DURATION;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; FOOT DERMATOSES; HUMANS; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; SKIN DISEASES, BACTERIAL; SWIMMING POOLS;

EID: 37349090482     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02564.x     Document Type: Article

References (10)

1. Mufti AH, Toye BW, McKendry RR. Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use. Diagn Micrbol Infect Dis 2005 53 : 233 8.
2. Marie I, Heliot P, Roussel F et al. Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab. Rheumatology (Oxford) 2005 44 : 1201 2.
3. Chopra N, Kirshenbaum AE, Widman D. Mycobacterium marinum tenosynovitis in a patient on etanercept therapy for rheumatoid arthritis. J Clin Rheumatol 2002 8 : 265 8.
4. Yates VM, Rook GAW. Mycobacterial infections. In : Rook's Textbook of Dermatology (Burns T, Breathnach S, Cox N, Griffiths C, eds), 7th edn. Blackwell Science Ltd, 2004 : 28.28 28. 31.
5. Barton A, Bernstein RM, Struthers JK et al. Mycobacterium marinum infection causing septic arthritis and osteomyelitis. Br J Rheumatol 1997 36 : 1207 9.
6. Camussi G, Albano E, Tetta C et al. The molecular action of tumour necrosis factor-alpha. Eur J Biochem 1991 202 : 3 14.
7. Kavanaugh A, St Clair EW, McCune WJ et al. Chimeric anti-tumour necrosis-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. J Rheumatol 2000 27 : 841 50.
8. Keane J, Gershon S, Wise R et al. Tuberculosis associated with infliximab, a tumour necrosis factor alpha-neutralizing agent. N Engl J Med 2001 345 : 1098 1104.
9. Smith CH, Anstey AV, Barker JN et al. British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 2005 153 : 486 97.
10. Streit M, Bohlen LM, Hunziker T et al. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur J Dermatol 2006 16 : 79 83.